TuHURA Biosciences adopted the 2026 Inducement Equity Incentive Plan on September 10, 2026, reserving 5,000,000 shares of common stock for issuance to new employees as a material inducement. The plan allows grants of nonqualified stock options and other equity awards but excludes incentive stock options, with exercise prices set at or above the closing market price on the grant date. No awards have been granted yet, and the company will announce future grants via press release in compliance with Nasdaq Listing Rule 5635(c)(4). This biotechnology company develops therapies for rare diseases.
